The initiation of coverage by BTIG with a Buy rating and a specific price target of $6 suggests a positive outlook for Outset Medical's stock in the short term. Analyst ratings, especially from reputable firms like BTIG, can influence investor sentiment and potentially lead to an increase in stock price as the market reacts to the new information.